Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2400100	口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗（人二倍体细胞）	Poliomyelitis (Live) Vaccine TypeⅠ Type Ⅲ (Human Diploid Cell)	Oral solution	Biological Products	Supplementary Application	2024-04-26		Institute of Medical Biology Chinese Academy of Medical Sciences			view
CYSB2000206	口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗（人二倍体细胞）	Poliomyelitis (Live) Vaccine TypeⅠ Type Ⅲ (Human Diploid Cell)	Oral solution	Biological Products	Supplementary Application	2020-08-27	北京生物制品研究所有限责任公司	Beijing Institute of Biological Products Co Ltd	In Review	2020-08-25	view
CYSB2000205	口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗（人二倍体细胞）	Poliomyelitis (Live) Vaccine TypeⅠ Type Ⅲ (Human Diploid Cell)	Oral solution	Biological Products	Supplementary Application	2020-08-27	北京生物制品研究所有限责任公司	Beijing Institute of Biological Products Co Ltd	In Review	2020-08-25	view
CYSB1700008	口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗（人二倍体细胞）	Poliomyelitis (Live) Vaccine TypeⅠ Type Ⅲ (Human Diploid Cell)	Oral solution	Biological Products	Supplementary Application	2017-03-22	北京北生研生物制品有限公司	Beijing Institute of Biological Products Co Ltd	Certificate Issued	2017-06-09	view